Navigation Links
Avanir Pharmaceuticals Announces Paragraph IV ANDA Filing for NUEDEXTA
Date:7/1/2011

NUEDEXTA® is the first and only FDA-approved treatment for pseudobulbar affect (PBA). NUEDEXTA is an innovative combination of two well-characterized components; dextromethorphan hydrobromide (20 mg), the ingredient active in the central nervous system, and quinidine sulfate (10 mg), a metabolic inhibitor enabling therapeutic dextromethorphan concentrations. NUEDEXTA acts on sigma-1 and NMDA receptors in the brain, although the mechanism by which NUEDEXTA exerts therapeutic effects in patients with PBA is unknown.

NUEDEXTA is indicated for the treatment of pseudobulbar affect (PBA). PBA occurs secondary to a variety of otherwise unrelated neurological conditions, and is characterized by involuntary, sudden, and frequent episodes of laughing and/or crying. PBA episodes typically occur out of proportion or incongruent to the patient's underlying emotional state. Studies to support the effectiveness of NUEDEXTA were performed in patients with amyotrophic lateral sclerosis (ALS) and multiple sclerosis (MS). NUEDEXTA has not been shown to be safe and effective in other types of emotional lability that can commonly occur, for example, in Alzheimer's disease and other dementias. The primary outcome measure, laughing and crying episodes, was significantly lower in the NUEDEXTA arm compared to placebo. The secondary outcome measure, the Center for Neurologic Studies Lability Scale (CNS-LS), demonstrated a significantly greater mean decrease in CNS-LS score from baseline for the NUEDEXTA arm compared to placebo.

NUEDEXTA Important Safety Information

NUEDEXTA can interact with other medications causing significant changes in blood levels of those medications and/or NUEDEXTA. NUEDEXTA is contraindicated in patients receiving drugs that both prolong QT interval and are metabolized by CYP2D6 (e.g., thioridazine and pimozide) and should not be used concomitantly with other drugs containing quinidine, quinine, or mefloquine. NUEDEXTA is contraindica
'/>"/>

SOURCE Avanir Pharmaceuticals, Inc.
Copyright©2010 PR Newswire.
All rights reserved

Page: 1 2 3 4

Related medicine technology :

1. AVANIR Pharmaceuticals Invites Investors to Fiscal 2010 Third Quarter Conference Call
2. AVANIR Pharmaceuticals to Present at the UBS Global Life Sciences Conference
3. AVANIR Pharmaceuticals Announces FDA Approval of NUEDEXTA™
4. AVANIR Pharmaceuticals Invites Investors to Conference Call Regarding FDA Approval of NUEDEXTA™ on Monday November 1, 2010
5. AVANIR Pharmaceuticals Announces Pricing of Public Offering of Common Stock
6. AVANIR Pharmaceuticals Announces NASDAQ Opening Bell Ceremony
7. AVANIR Pharmaceuticals Invites Investors to Fiscal 2011 First Quarter Conference Call
8. AVANIR Pharmaceuticals Announces Fiscal 2011 First Quarter Financial Results
9. AVANIR Pharmaceuticals Appoints Gregory J. Flesher to Senior Vice President and Chief Business Officer
10. Avanir Pharmaceuticals to Present at Three Conferences in March
11. Avanir Pharmaceuticals to Present at BioCentury Future Leaders in the Biotech Industry Conference
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:3/30/2015)... , March 30, 2015 Perrigo Company ... provider of "Quality Affordable Healthcare Products®," today announced that ... Invest N.V. ("Omega") in a cash and equity transaction ... of €1.3 billion in debt. Sellers are Marc ... co-investors of Waterland.    "The ...
(Date:3/30/2015)...  MedAptus® today announced the launch of Assign, ... needs for busy inpatient provider teams. Assign was ... to hospitalists or other rounding providers based on ... such as ensuring patient safety, proper reimbursement and ... In an increasingly risk-based healthcare ...
(Date:3/30/2015)... 30, 2015  Edison Nation Medical, the premier ... for product innovations to assist seniors in staying ... during the 8-week search will be presented to ... ideas can be submitted through a secure, confidential ... 28, 2015. The objective of the ...
Breaking Medicine Technology:Perrigo Company plc Completes Acquisition Of Omega Pharma Invest N.V., Creating A Top Five Global OTC Company 2Perrigo Company plc Completes Acquisition Of Omega Pharma Invest N.V., Creating A Top Five Global OTC Company 3Perrigo Company plc Completes Acquisition Of Omega Pharma Invest N.V., Creating A Top Five Global OTC Company 4Perrigo Company plc Completes Acquisition Of Omega Pharma Invest N.V., Creating A Top Five Global OTC Company 5MedAptus Launches Automated Patient Assignment Solution for Hospitalists, Other Rounding Specialists 2MedAptus Launches Automated Patient Assignment Solution for Hospitalists, Other Rounding Specialists 3Edison Nation Medical Announces Open Innovation Search Focused on Senior Mobility Products 2Edison Nation Medical Announces Open Innovation Search Focused on Senior Mobility Products 3
... -- LEUVEN, Belgium, September 6, 2010 ... ... ... are keyed by longUrl, so we need to grab the first one. for (var r in data.results) ...
... O R R E C T I O N - Mindray Medical... -- SHENZHEN, China, Aug. 25 /PRNewswire-Asia-FirstCall/ ... ... if (typeof(lpUnit)==,undefined,) var lpUnit=,PRN,; --> ... function(data) { var s = ,; var first_result; // Results are keyed by longUrl, so we need to ...
Cached Medicine Technology:ThromboGenics Presents Positive Pooled Results from the MIVI-TRUST Phase III Program, Confirming Microplasmin's Potential to Transform the Treatment of Retinal Disorders 2ThromboGenics Presents Positive Pooled Results from the MIVI-TRUST Phase III Program, Confirming Microplasmin's Potential to Transform the Treatment of Retinal Disorders 3ThromboGenics Presents Positive Pooled Results from the MIVI-TRUST Phase III Program, Confirming Microplasmin's Potential to Transform the Treatment of Retinal Disorders 4ThromboGenics Presents Positive Pooled Results from the MIVI-TRUST Phase III Program, Confirming Microplasmin's Potential to Transform the Treatment of Retinal Disorders 5ThromboGenics Presents Positive Pooled Results from the MIVI-TRUST Phase III Program, Confirming Microplasmin's Potential to Transform the Treatment of Retinal Disorders 6ThromboGenics Presents Positive Pooled Results from the MIVI-TRUST Phase III Program, Confirming Microplasmin's Potential to Transform the Treatment of Retinal Disorders 7ThromboGenics Presents Positive Pooled Results from the MIVI-TRUST Phase III Program, Confirming Microplasmin's Potential to Transform the Treatment of Retinal Disorders 8ThromboGenics Presents Positive Pooled Results from the MIVI-TRUST Phase III Program, Confirming Microplasmin's Potential to Transform the Treatment of Retinal Disorders 9ThromboGenics Presents Positive Pooled Results from the MIVI-TRUST Phase III Program, Confirming Microplasmin's Potential to Transform the Treatment of Retinal Disorders 10/C O R R E C T I O N - Mindray Medical International Limited / 2/C O R R E C T I O N - Mindray Medical International Limited / 3/C O R R E C T I O N - Mindray Medical International Limited / 4/C O R R E C T I O N - Mindray Medical International Limited / 5/C O R R E C T I O N - Mindray Medical International Limited / 6/C O R R E C T I O N - Mindray Medical International Limited / 7
(Date:3/31/2015)... San Diego, CA (PRWEB) March 31, 2015 ... the American Heart Association and the Burn Institute, Bill Howe ... and military programs initiated by their own employees. One ... Harp Fest held in La Mesa, Ca. The San Diego ... the event organizers together with their field supervisor, an accomplished ...
(Date:3/31/2015)... March 31, 2015 “ Prong ” was ... which features the latest and coolest technology products available to ... NewsWatch, conducted the review and shared with viewers how this ... , Everyone knows that feeling when their phone is running ... there's a new phone case that is a solution to ...
(Date:3/31/2015)... Lewisville, TX (PRWEB) March 31, 2015 ... of independent freestanding emergency rooms in the United States, ... in April. , “I am pleased to announce ... Dallas-Fort Worth metroplex in Haslet,” said Dr. James M. ... , First Choice Emergency Room is revolutionizing the ...
(Date:3/31/2015)... 31, 2015 . All the work that ... of emphasis is laid upon helping our clients in maintaining ... much as missing teeth and this problem needs to be ... teeth not only play a key role in shattering one’s ... , Considering the importance of this problem, Lewis Clinic ...
(Date:3/31/2015)... A new study by Health eCareers found ... employee turnover as their greatest staffing concern this year and ... battle – once you have them, you need to keep ... trends in healthcare recruiting blog series , which profiles the ... in hospitals has high numbers and results in high costs ...
Breaking Medicine News(10 mins):Health News:Bill Howe Plumbing, Inc. Sponsors Spring Harp Fest for the Sixth Year 2Health News:Bill Howe Plumbing, Inc. Sponsors Spring Harp Fest for the Sixth Year 3Health News:The Swiss Army Knife of Phone Cases was Featured on NewsWatch Television 2Health News:First Choice Emergency Room to Open New Facility in Haslet, Texas 2Health News:New Survey Finds Staff Turnover Top Concern for Healthcare Recruiters in 2015 2Health News:New Survey Finds Staff Turnover Top Concern for Healthcare Recruiters in 2015 3Health News:New Survey Finds Staff Turnover Top Concern for Healthcare Recruiters in 2015 4
... About Dangers of Medicating Children, Fleming ... Cold Prevention Strategies, ST. LOUIS, Sept. 19 ... the U.S. Food and Drug,Administration for use with young ... parents to help prevent their,children from catching colds in ...
... If you,ve been experiencing watery,eyes and excessive sneezing, ... the U.S., with an estimated 50 million Americans suffering. ... tune of 3 billion,dollars a year, often without knowing ... blood tests, the latest generation of,allergy tests, can help ...
... finds , WEDNESDAY, Sept. 19 (HealthDay News) -- If the ... is too quiet, it could mean that they,re being suppressed ... researchers warn. , A team at the University of Toledo, ... cells collected via bronchoscopy could help identify people genetically at ...
... Vaccine supplies are plentiful this year, but inoculation rates ... News) -- Too many Americans aren,t getting vaccinated for ... children and health-care workers -- U.S. health officials warned ... vaccine, we are still failing to protect a large ...
... are to be injected into those with cancer to ... of Medicine in Winston-Salem, North Carolina, and his colleagues ... Administration (FDA) to screen people for their ability to ... fighters will be given to cancer patients, after being ...
... will,have access to high-quality, evidence-based care for behavioral ... Senate. The,"Mental Health Parity Act of 2007" would ... provide parity with respect to all financial,requirements and ... ) "AHIP applauds the Senate for coming ...
Cached Medicine News:Health News:Countering Colds With Common Sense 2Health News:Countering Colds With Common Sense 3Health News:Hushed Genes Might Mean Higher Lung Cancer Risk 2Health News:More Americans Urged to Get Flu Shots 2Health News:More Americans Urged to Get Flu Shots 3Health News:Their immune cells, fighting your cancer 2
... ergonomic chairs with concave seats and ... Select options like seats, backrests, armrests, ... chairs are recommended for the following ... static control, health care and office. ...
... chairs with concave seats and standard-sized ... options like seats, backrests, armrests, and ... are recommended for the following environments: ... control, health care and office. • ...
... Basic ergonomic chairs with concave ... support • Select options like seats, ... • BTC/1Q chairs are recommended for ... clean room, static control, health care ...
... Basic ergonomic chairs with concave seats ... • Select options like seats, backrests, ... BTC/1Q chairs are recommended for the ... room, static control, health care and ...
Medicine Products: